Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Are Craneware plc (LON:CRW) Investors Paying Above The Intrinsic Value?

Key Insights Craneware's estimated fair value is UK£10.18 based on 2 Stage Free Cash Flow to Equity Current share price of UK£13.30 suggests Craneware is potentially 31% overvalued Our fair value estimate is 61% lower than Craneware's analyst price target of US$25.77 In this …

EODHD | 27 May 2023

Why Victoria PLC (LON:VCP) Looks Like A Quality Company

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). We'll use ROE to examine Victoria PLC (LON:VCP), by way of a …

EODHD | 27 May 2023

Sims Limited Achieves Climate Leaders Asia-Pacific 2023 Recognition

– Identified by Financial Times and Statista for second consecutive year as setting the pace in the fight against climate change – SYDNEY, May 27, 2023--(BUSINESS WIRE)--Sims Limited (ASX: SGM), a global leader in sustainability and an enabler of the circular economy, has been …

EODHD | 27 May 2023

Is It Time To Consider Buying NRW Holdings Limited (ASX:NWH)?

NRW Holdings Limited (ASX:NWH), is not the largest company out there, but it received a lot of attention from a substantial price movement on the ASX over the last few months, increasing to AU$2.96 at one point, and dropping to the lows of AU$2.10. …

EODHD | 27 May 2023

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 29% Above Their Intrinsic Value Estimate

Key Insights Using the 2 Stage Free Cash Flow to Equity, Fisher & Paykel Healthcare fair value estimate is NZ$18.66 Current share price of NZ$23.98 suggests Fisher & Paykel Healthcare is potentially 29% overvalued Analyst price target for FPH is NZ$24.53, which is 31% …

EODHD | 26 May 2023

Volpara Health Technologies Limited (ASX:VHT) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Volpara Health Technologies Limited (ASX:VHT) last week reported its latest yearly results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. It was a pretty bad result overall; while revenues were …

EODHD | 26 May 2023

Oceania Healthcare's (NZSE:OCA) Dividend Is Being Reduced To NZ$0.013

Oceania Healthcare Limited (NZSE:OCA) is reducing its dividend to NZ$0.013 on the 21st of Junewhich is 43% less than last year's comparable payment of NZ$0.023. The dividend yield of 5.6% is still a nice boost to shareholder returns, despite the cut. See our latest …

EODHD | 26 May 2023

Oncolytics Biotech® to Host Key Opinion Leader Webinar on Data from the Randomized BRACELET-1 Trial in HR+/HER2- Metastatic Breast Cancer Being Presented at the Upcoming ASCO Annual Meeting

Key opinion leader webinar to take place on June 5, 2023 at 8:00 a.m. ET SAN DIEGO and CALGARY, AB, May 26, 2023 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) announced that it will host a key opinion leader webinar to discuss …

EODHD | 26 May 2023

Creo Medical Group "really pleased" with first human trial of lung lesion treatment

London, UK --News Direct-- Creo Medical Group PLC Creo Medical Group PLC (AIM:CREO) CEO Craig Gulliford speaks to Thomas Warner from Proactive after announcing the successful completion of a first human trial of its pioneering MicroBlate Flex device for soft tissue lung lesion microwave …

EODHD | 26 May 2023

Pan African Resources confident in tailwinds after revising production guidance

London, UK --News Direct-- Pan African Resources PLC Pan African Resources PLC (AIM:PAF, OTCQX:PAFRY, JSE:PAN, OTCQX:PAFRF) CEO Cobus Loots speaks to Thomas Warner from Proactive after releasing revised production guidance for the year ending 30 June 2023. Loots gives more detail about what's been …

EODHD | 26 May 2023

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions